{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:20:12Z","timestamp":1770499212026,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10067-016-3314-x","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T01:19:23Z","timestamp":1464225563000},"page":"1937-1942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Elevated high-mobility group B1 levels in active adult-onset Still\u2019s disease associated with systemic score and skin rash"],"prefix":"10.1007","volume":"35","author":[{"given":"Ju-Yang","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonghyang","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"3314_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG (1971) Still\u2019s disease in the adult. Ann Rheum Dis 30:121\u2013133","journal-title":"Ann Rheum Dis"},{"key":"3314_CR2","first-page":"1058","volume":"17","author":"A Ohta","year":"1990","unstructured":"Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Akizuki M et al (1990) Adult Still\u2019s disease: a multicenter survey of Japanese patients. J Rheumatol 17:1058\u20131063","journal-title":"J Rheumatol"},{"key":"3314_CR3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","volume":"32","author":"HA Kim","year":"2012","unstructured":"Kim HA, Sung JM, Suh CH (2012) Therapeutic responses and prognosis in adult-onset Still\u2019s disease. Rheumatol Int 32:1291\u20131298","journal-title":"Rheumatol Int"},{"key":"3314_CR4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncprheum0510","volume":"3","author":"P Efthimiou","year":"2007","unstructured":"Efthimiou P, Kontzias A, Ward CM, Ogden NS (2007) Adult-onset Still\u2019s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 3:328\u2013335","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3314_CR5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Seve P (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13:708\u2013722","journal-title":"Autoimmun Rev"},{"key":"3314_CR6","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1097\/MD.0000000000000787","volume":"94","author":"HA Kim","year":"2015","unstructured":"Kim HA, Kwon JE, Yim H, Suh CH, Jung JY, Han JH (2015) The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset still disease: a comprehensive analysis of 40 cases. Medicine (Baltimore) 94:e787","journal-title":"Medicine (Baltimore)"},{"key":"3314_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1546-0096-10-40","volume":"10","author":"S Kumar","year":"2012","unstructured":"Kumar S, Kunhiraman DS, Rajam L (2012) Application of the Yamaguchi criteria for classification of \u201csuspected\u201d systemic juvenile idiopathic arthritis (sJIA). Pediatr Rheumatol Online J 10:40","journal-title":"Pediatr Rheumatol Online J"},{"key":"3314_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Seve P (2015) Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res 61:53\u201362","journal-title":"Immunol Res"},{"key":"3314_CR9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00296-009-1291-y","volume":"30","author":"V Bagnari","year":"2010","unstructured":"Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset Still\u2019s disease. Rheumatol Int 30:855\u2013862","journal-title":"Rheumatol Int"},{"key":"3314_CR10","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. J Rheumatol 31:2189\u20132198","journal-title":"J Rheumatol"},{"key":"3314_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","volume":"17","author":"JH Han","year":"2015","unstructured":"Han JH, Suh CH, Jung JY, Nam JY, Kwon JE, Yim H, Kim HA (2015) Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still\u2019s disease. Arthritis Res Ther 17:260","journal-title":"Arthritis Res Ther"},{"key":"3314_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/joim.12309","volume":"276","author":"U Andersson","year":"2014","unstructured":"Andersson U, Antoine DJ, Tracey KJ (2014) The functions of HMGB1 depend on molecular localization and post-translational modifications. J Intern Med 276:420\u2013424","journal-title":"J Intern Med"},{"key":"3314_CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476\u2013484","journal-title":"Mol Med"},{"key":"3314_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","volume":"8","author":"HE Harris","year":"2012","unstructured":"Harris HE, Andersson U, Pisetsky DS (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8:195\u2013202","journal-title":"Nat Rev Rheumatol"},{"key":"3314_CR15","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar3450","volume":"13","author":"H Wahamaa","year":"2011","unstructured":"Wahamaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, Harris HE (2011) High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther 13:R136","journal-title":"Arthritis Res Ther"},{"key":"3314_CR16","first-page":"946748","volume":"2015","author":"M Lu","year":"2015","unstructured":"Lu M, Yu S, Xu W, Gao B, Xiong S (2015) HMGB1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response. J Immunol Res 2015:946748","journal-title":"J Immunol Res"},{"key":"3314_CR17","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T et al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"key":"3314_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D et al (1991) Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118\u2013136","journal-title":"Medicine (Baltimore)"},{"key":"3314_CR19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3314_CR20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686","journal-title":"Arthritis Rheum"},{"key":"3314_CR21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","volume":"39","author":"HA Kim","year":"2012","unstructured":"Kim HA, An JM, Nam JY, Jeon JY, Suh CH (2012) Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still\u2019s disease. J Rheumatol 39:1399\u20131406","journal-title":"J Rheumatol"},{"key":"3314_CR22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3899\/jrheum.140651","volume":"41","author":"CB Bae","year":"2014","unstructured":"Bae CB, Suh CH, An JM, Jung JY, Jeon JY, Nam JY, Kim HA (2014) Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still\u2019s disease. J Rheumatol 41:2403\u20132408","journal-title":"J Rheumatol"},{"key":"3314_CR23","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","volume":"58","author":"H Wittkowski","year":"2008","unstructured":"Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, Fruhwald MC, Dassmann S, Pham TH, Roth J et al (2008) S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 58:3924\u20133931","journal-title":"Arthritis Rheum"},{"key":"3314_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29:139\u2013162","journal-title":"Annu Rev Immunol"},{"key":"3314_CR25","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.4049\/jimmunol.181.6.4240","volume":"181","author":"G Liu","year":"2008","unstructured":"Liu G, Wang J, Park YJ, Tsuruta Y, Lorne EF, Zhao X, Abraham E (2008) High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 181:4240\u20134246","journal-title":"J Immunol"},{"key":"3314_CR26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ket134","volume":"52","author":"Y Chen","year":"2013","unstructured":"Chen Y, Sun W, Gao R, Su Y, Umehara H, Dong L, Gong F (2013) The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology (Oxford) 52:1739\u20131747","journal-title":"Rheumatology (Oxford)"},{"key":"3314_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ncprheum0379","volume":"3","author":"W Jiang","year":"2007","unstructured":"Jiang W, Pisetsky DS (2007) Mechanisms of disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat Clin Pract Rheumatol 3:52\u201358","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3314_CR28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","volume":"48","author":"N Taniguchi","year":"2003","unstructured":"Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S et al (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971\u2013981","journal-title":"Arthritis Rheum"},{"key":"3314_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10238-010-0116-3","volume":"11","author":"HF Guo","year":"2011","unstructured":"Guo HF, Liu SX, Zhang YJ, Liu QJ, Hao J, Gao LX (2011) High mobility group box 1 induces synoviocyte proliferation in rheumatoid arthritis by activating the signal transducer and activator transcription signal pathway. Clin Exp Med 11:65\u201374","journal-title":"Clin Exp Med"},{"key":"3314_CR30","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.11161","volume":"48","author":"R Kokkola","year":"2003","unstructured":"Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, Tracey KJ, Andersson U, Harris HE (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48:2052\u20132058","journal-title":"Arthritis Rheum"},{"key":"3314_CR31","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3899\/jrheum.120987","volume":"40","author":"H Schierbeck","year":"2013","unstructured":"Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius A, Sundberg E, Harris HE (2013) HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration. J Rheumatol 40:1604\u20131613","journal-title":"J Rheumatol"},{"key":"3314_CR32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1546-0096-12-50","volume":"12","author":"D Bobek","year":"2014","unstructured":"Bobek D, Grcevic D, Kovacic N, Lukic IK, Jelusic M (2014) The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Pediatr Rheumatol Online J 12:50","journal-title":"Pediatr Rheumatol Online J"},{"key":"3314_CR33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00403-013-1330-0","volume":"305","author":"T Chen","year":"2013","unstructured":"Chen T, Guo ZP, Li L, Wang L, Jia RZ, Cao N, Qin S, Li MM (2013) Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris. Arch Dermatol Res 305:263\u2013267","journal-title":"Arch Dermatol Res"},{"key":"3314_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0961203313483377","volume":"22","author":"DA Abdulahad","year":"2013","unstructured":"Abdulahad DA, Westra J, Reefman E, Zuidersma E, Bijzet J, Limburg PC, Kallenberg CG, Bijl M (2013) High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE). Lupus 22:597\u2013606","journal-title":"Lupus"},{"key":"3314_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagrm.2009.11.003","volume":"1799","author":"U Andersson","year":"2010","unstructured":"Andersson U, Harris HE (2010) The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta 1799:141\u2013148","journal-title":"Biochim Biophys Acta"},{"key":"3314_CR36","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s12272-012-0901-5","volume":"35","author":"JS Bae","year":"2012","unstructured":"Bae JS (2012) Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res 35:1511\u20131523","journal-title":"Arch Pharm Res"},{"key":"3314_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/ar2427","volume":"10","author":"RS Goldstein","year":"2008","unstructured":"Goldstein RS (2008) High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis. Arthritis Res Ther 10:111","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3314-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3314-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:59:32Z","timestamp":1559120372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3314"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3314-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}